Evidence map›Paper›PMID 11444424›Full record

ReviewEndocrine2001

Hormonal regulation and implication of cell signaling in calcium transfer by placenta.

J Lafond, I Goyer-O'Reilly, M Laramée, L Simoneau

Abstract readReview
PubMed Publisher
In one paragraph

Review in Endocrine, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 28 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

J LafondDépartement des Sciences Biologiques, Université du Québec à Montréal, Canada. lafond.julie@uqam.ca
I Goyer-O'Reilly
M Laramée
L Simoneau
Université du Québec à Montréal · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During pregnancy, the human placenta transfers about 30 g of calcium (Ca2+) from the mother to the fetus. This transfer is mainly done during the third trimester, at a rate of 140 mg/(kg x d). It allows adequate growth and development of the fetus, since Ca2+ is vital for the mineralization of the fetus's skeleton and many cellular functions. Because Ca2+ flows through the placenta against an electrochemical gradient, calcemic hormones could also be involved to overcome this gradient. Hormones such as calcitonin, parathyroid hormone (PTH), and PTH-related peptide (PTHrP) have been found in maternal and fetal circulation, and they originate from both parties, as well as from the placenta in the case of PTHrP. As the placenta possesses most of the G-protein-coupled receptors to bind these hormones, it is likely that they play an important role in maternal-fetal Ca2+ homeostasis. More studies are needed to assess the importance of these hormones in the regulation of Ca2+ management during pregnancy, and to understand better the cell-signaling pathways involved. This article addresses the current knowledge in this field to guide future investigations on the roles, functions, and localizations of the components involved during Ca2+ transfer by syncytiotrophoblasts.

Indexed as

AnimalsCalciumCalcium SignalingFemaleHormonesHumansParathyroid HormonePlacentaPregnancyCalciumHormonesParathyroid Hormone

Identifiers

PMID11444424
OpenAlexW2044069688

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.